Who to call at ANI Pharmaceuticals, Inc., and when
Fundz watches for the moments ANI Pharmaceuticals, Inc. starts buying, and tells you who to reach.
- An alert the day ANI Pharmaceuticals, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ANI Pharmaceuticals, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ANI Pharmaceuticals, Inc.. With Fundz connected, it knows.
ANI Pharmaceuticals, Inc.
A senior executive or director joined, left, or changed roles. An 8-K is the notice a US public company must file within four business days of a major event.
anipharmaceuticals.comAI Executive Summary
AI-powered analysis of 8-K filing content
ANI Pharmaceuticals disclosed that Chairman Patrick D. Walsh stepped down as Chairman and will not seek re-election at the 2026 Annual Meeting, though he will remain a director until then. Thomas J. Haughey was elected Chairman, and Jeanne A. Thoma replaced him as Chair of the Audit and Finance Committee. The company said Walsh's decision was not due to any disagreement with the Board or management.
Key Takeaways
Patrick D. Walsh stepped down as Chairman of the Board and will not stand for re-election as a director at the 2026 Annual Meeting, but he will serve until that meeting.
Thomas J. Haughey was elected Chairman of the Board, succeeding Walsh.
2 more takeaways
Related Filings (6)
6 more filings from ANI Pharmaceuticals, Inc. in the last 90 days
Filing Overview
What This Means
ANI Pharmaceuticals, Inc. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.